Your browser doesn't support javascript.
loading
Stereotactic pelvic radiotherapy with HDR boost for dose escalation in intermediate and high-risk prostate cancer (SPARE): Efficacy, toxicity and quality of life.
Musunuru, Hima Bindu; Cheung, Patrick; Vesprini, Danny; Liu, Stanley K; Chu, William; Chung, Hans T; Morton, Gerard; Deabreu, Andrea; Davidson, Melanie; Ravi, Ananth; Helou, Joelle; Ho, Ling; Zhang, Liying; Loblaw, Andrew.
Afiliación
  • Musunuru HB; Department of Radiation Oncology, University of Pittsburg, United States.
  • Cheung P; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Canada; Department of Radiation Oncology, University of Toronto, Canada.
  • Vesprini D; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Canada; Department of Radiation Oncology, University of Toronto, Canada.
  • Liu SK; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Canada; Department of Radiation Oncology, University of Toronto, Canada.
  • Chu W; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Canada; Department of Radiation Oncology, University of Toronto, Canada.
  • Chung HT; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Canada; Department of Radiation Oncology, University of Toronto, Canada.
  • Morton G; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Canada; Department of Radiation Oncology, University of Toronto, Canada.
  • Deabreu A; Clinical Trials and Epidemiology Program, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Canada.
  • Davidson M; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Canada; Department of Radiation Oncology, University of Toronto, Canada.
  • Ravi A; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Canada; Department of Radiation Oncology, University of Toronto, Canada.
  • Helou J; Department of Radiation Oncology, University of Toronto, Canada; Princess Margaret Cancer Centre, Canada.
  • Ho L; Department of Radiation Oncology, University of Toronto, Canada.
  • Zhang L; Clinical Trials and Epidemiology Program, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Canada.
  • Loblaw A; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Canada; Department of Radiation Oncology, University of Toronto, Canada; Institute of Health Policy, Management and Evaluation, Canada. Electronic address: andrew.loblaw@sunnybrook.ca.
Radiother Oncol ; 161: 40-46, 2021 08.
Article en En | MEDLINE | ID: mdl-34089752
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Braquiterapia Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Qualitative_research / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Radiother Oncol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Braquiterapia Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Qualitative_research / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Radiother Oncol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos